Ready to Participate?
Already a member?
Have a question?
Join the MD Analytics Healthcare Professional Market Research Panel and you will be invited to participate in paid health-related market research studies, such as online surveys, virtual interviews, and in-person focus groups.
Frequently Asked Questions about MD Analytics
MD Analytics provides market research services for the healthcare and pharmaceutical industry. We are committed to following the highest standards and care within our industry, abiding by the codes of conduct of the Canadian Research Insights Council, ESOMAR, and the Insights Association.
Why should I join the panel?
Participating in our market research studies provides opportunities for healthcare professionals to voice their opinions and inform key decisions impacting health policy and patient care. Participants also benefit from learning opportunities obtained through participating in market research and from incentives earned in exchange for their time and expert contribution.
What happens after I join?
Upon signing up to join the panel, you will be sent invitations via email to participate in online surveys, telephone interviews and/or focus groups that are relevant to your health profession and area of specialty. The study invitation will always indicate the type of study, topic, length of time required to complete the study and the incentive amount.
You decide whether a study interests you and participate as you wish. Upon completing a study, you will be paid the incentive specified.
How will my privacy be protected?
MD Analytics is committed to protecting the privacy of its research participants. When participating in our market research studies, all your responses remain anonymous and there is never any follow-up or attempt made to sell you anything.
MD Analytics is an Accredited Agency of the Canadian Research Insights Council and a member in good standing of the Insights Association. As such we are committed to going above and beyond these associations’ code of conduct, adhering to an audit every two years, to ensure we meet the highest standards.
Ready to join?
What will the content of the survey be used for and for whom?
The research sponsor and purpose will vary depending on the study. To not bias the research, we are unable to reveal their identity. However, most of our clients are multi-national pharmaceutical companies specializing in developing products and treatments for the therapeutic area of the study topic.
Are my responses anonymous?
Absolutely, your responses are anonymous. As a third-party market research firm, we never share your personal identifiable information with the research sponsor. Your responses will never be tied back to you as an individual. We always present the research findings as an aggregate between what you and your colleagues have collectively answered.
Will my name, title, or contact information be shared with research sponsors or publications?
No, we will never share that information to our clients nor any publications. If we need data from any of our physician panelists for a publication, we will state it explicitly in the first page of the survey and will ask for your consent to proceed.
How do I know if I qualify to participate?
Every online survey starts with a short eligibility section followed by the main survey. Each survey has different screening requirements, so we cannot guarantee eligibility every time. Every eligibility section will typically take from 15 seconds up to 2 minutes of your time.
What do you do with the data collected in the eligibility section?
We discard the data from the eligibility section, if you do not qualify to answer the main study questions. The data from the eligibility section is used for profiling and it is not useful for the study if it is not coupled with answers for the main survey.
How do I verify if the research is legitimate?
You can search the validity of our studies on the CRIC research verification service.
“MD Analytics surveys provides a great learning experience as well as stimulating my interests in certain topics to look deeper and try to incorporate ideas into my practice. Also you get paid for it! What more can you ask for!?”
Dr. W. Hu – GP and Surgical Assistant
Scarborough Health Network, Birchmount Site, ON
Dr. D. Kanji – Psychiatrist
Clinical Psychiatrist Toronto, ON
Dr. L. Knight – IM/Respirologist
Westmount Square Health Clinic, QC
Dr. Califaretti – Medical Oncologist
Grand River Hospital, ON
Dr. Bhavsar – Rheumatologist
Burlington Rheumatology Clinic, ON
Latest Survey Data
Market research plays a fundamental role in helping those involved in the healthcare market answer key questions about their brands. Gaining insights from healthcare practitioners is central to market research. However, engaging physicians to participate in research can be a challenge. While most of the surveyed physicians say they enjoy participating in market research studies, in practice, physicians self-report participating in less than half of the number of studies they are invited to participate in. Real-world experience from our panel says the response rate is even lower. With this in mind, we asked Canadian physicians to help us understand what motivates them to do market research.
Engaging prescribers is a key component to the launch of any new brand. But what are the key components that drive interest for physicians in learning more?
Overall, physicians express greater satisfaction when learning about new products through in person interactions compared to virtual or digital interactions. However, regardless of how they learn about new product, the types of resources physicians prefer are similar. The top most preferred resources for both GPs and Specialists include presentation at conferences, discussions with peers, educational events that include KOLs or treatment areas experts, presentations by lead authors, journal clubs and discussions with Pharmaceutical reps. While a majority agree (66%) they are more likely to engage with reps or MSLs to discuss new products or indications, more physicians agree (87%) they are more likely to meet with a rep or MSL with whom they have an established relationship.
The COVID-19 pandemic had a significant impact on physicians, including how they learn about and integrate new products into their practice. While not all saw a decline, close to 1 in 3 Specialists and close to half of GPs say their use of newly launched products declined during the pandemic, primarily due to a lack of pharma presence, reduced patient volumes overall and just a general lack of comfort using new products.